Lista de obras -

A case of granulomatosis with polyangiitis: rheumatoid arthritis overlap syndrome presenting as cervical cancer successfully treated with rituximab

artículo científico publicado en 2016

An International, Multi-Specialty Validation Study of the IgG4-Related Disease Responder Index

artículo científico publicado en 2018

Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis

scientific article published on 03 August 2019

Anti-PD1 therapy-associated cutaneous leucocytoclastic vasculitis: A case series

artículo científico publicado en 2018

Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature

artículo científico publicado en 2016

Arrhythmias in myocarditis: State of the art

artículo científico publicado en 2019

Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors

artículo científico publicado en 2022

Autoantibody-Mediated Depletion of IL-1RA in Still’s Disease and Potential Impact of IL-1 Targeting Therapies

artículo científico publicado en 2024

BRAF Mutations in Erdheim-Chester Disease

artículo científico publicado en 2016

BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease

artículo científico publicado en 2014

Bilateral temporal arteries 18F-FDG PET uptake in giant cell arteritis

artículo científico publicado en 2020

Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort

scholarly article

Clinically isolated aortitis successfully treated with methotrexate monotherapy

artículo científico publicado en 2020

Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease

scholarly article published in Arthritis Research and Therapy

Current treatment options and safety considerations when treating adult-onset Still's disease

artículo científico publicado en 2020

Diagnosing Erdheim–Chester disease ⬇️

artículo científico publicado el 16 de abril de 2013

Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis

scientific article published on 25 January 2020

Drug retention rates of biological agents in adult onset Still's disease

scientific article published on 11 December 2020

Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series

artículo científico publicado en 2018

Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease

scientific article published on 09 December 2019

Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience

artículo científico publicado en 2020

Efficacy and safety of mycophenolate mofetil in patients with virus-negative lymphocytic myocarditis: A prospective cohort study

artículo científico publicado en 2019

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study

scientific article published on 22 May 2020

Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease

artículo científico publicado en 2019

Erdheim-Chester disease.

artículo científico publicado en 2015

Erratum to: Guidelines for the use and interpretation of diagnostic methods in adult food allergy

artículo científico publicado en 2015

GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study

artículo científico publicado en 2020

Giant cell arteritis restricted to the limb arteries: An overlooked clinical entity.

artículo científico

Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey

scientific article published on 28 April 2020

Impact of systemic immune-mediated diseases on clinical features and prognosis of patients with biopsy-proved myocarditis

artículo científico publicado en 2018

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study

artículo científico publicado en 2021

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study

artículo científico publicado en 2020

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study

artículo científico publicado en 2020

Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab.

artículo científico

Large Vessel Vasculitis Affecting the Aorta and Its Branches in Relapsing Polychondritis: Case Series and Systematic Review of the Literature

scientific article published on 15 December 2019

Letter by Campochiaro et al Regarding Article, "Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity"

scientific article published on 01 May 2018

Living with fibromyalgia during the COVID-19 pandemic: mixed effects of prolonged lockdown on the well-being of patients

artículo científico publicado en 2020

Methotrexate in refractory bilateral juvenile temporal arteritis: Report of a case

artículo científico publicado en 2013

Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production

scientific article published in 2023

Myocarditis: An Interleukin-1-Mediated Disease?

artículo científico publicado en 2018

Nailfold capillaroscopy findings in patients with coronavirus disease 19: Broadening the spectrum of covid-19 microvascular involvement

artículo científico publicado en 2020

Nasal mucosa narrow band imaging in granulomatosis with polyangiitis (Wegener granulomatosis): A preliminary study

artículo científico publicado en 2015

Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease

artículo científico publicado en 2021

Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease

artículo científico publicado en 2016

Relationship Between Ventricular Arrhythmias, Conduction Disorders, and Myocardial Fibrosis in Patients With Systemic Sclerosis: The Role of Cardiac Magnetic Resonance

artículo científico publicado en 2018

Response to: 'Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey' by Comarmond et al

artículo científico publicado en 2020

Serum CXCL12 levels on hospital admission predict mortality in patients with severe sepsis/septic shock

artículo científico publicado en 2015

Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli

artículo científico publicado en 2020

The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature and of 10 new cases.

artículo científico

Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance: Report of Two Cases and Rationale for Its Therapeutic Use

scientific article published on 19 November 2019

Tocilizumab in patients with multisystem Erdheim-Chester disease

artículo científico publicado en 2017

Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.

artículo científico publicado en 2018

Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition

artículo científico publicado en 2018

Lista de obras de

A case of granulomatosis with polyangiitis: rheumatoid arthritis overlap syndrome presenting as cervical cancer successfully treated with rituximab

An International, Multi-Specialty Validation Study of the IgG4-Related Disease Responder Index

Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis

Anti-PD1 therapy-associated cutaneous leucocytoclastic vasculitis: A case series

Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature

Arrhythmias in myocarditis: State of the art

Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors

Autoantibody-Mediated Depletion of IL-1RA in Still’s Disease and Potential Impact of IL-1 Targeting Therapies

BRAF Mutations in Erdheim-Chester Disease

BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease

Bilateral temporal arteries 18F-FDG PET uptake in giant cell arteritis

Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort

Clinically isolated aortitis successfully treated with methotrexate monotherapy

Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease

Current treatment options and safety considerations when treating adult-onset Still's disease

Diagnosing Erdheim–Chester disease ⬇️

Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis

Drug retention rates of biological agents in adult onset Still's disease

Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series

Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease

Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience

Efficacy and safety of mycophenolate mofetil in patients with virus-negative lymphocytic myocarditis: A prospective cohort study

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study

Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease

Erdheim-Chester disease.

Erratum to: Guidelines for the use and interpretation of diagnostic methods in adult food allergy

GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study

Giant cell arteritis restricted to the limb arteries: An overlooked clinical entity.

Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey

Impact of systemic immune-mediated diseases on clinical features and prognosis of patients with biopsy-proved myocarditis

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study

Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab.

Large Vessel Vasculitis Affecting the Aorta and Its Branches in Relapsing Polychondritis: Case Series and Systematic Review of the Literature

Letter by Campochiaro et al Regarding Article, "Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity"

Living with fibromyalgia during the COVID-19 pandemic: mixed effects of prolonged lockdown on the well-being of patients

Methotrexate in refractory bilateral juvenile temporal arteritis: Report of a case

Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production

Myocarditis: An Interleukin-1-Mediated Disease?

Nailfold capillaroscopy findings in patients with coronavirus disease 19: Broadening the spectrum of covid-19 microvascular involvement

Nasal mucosa narrow band imaging in granulomatosis with polyangiitis (Wegener granulomatosis): A preliminary study

Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease

Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease

Relationship Between Ventricular Arrhythmias, Conduction Disorders, and Myocardial Fibrosis in Patients With Systemic Sclerosis: The Role of Cardiac Magnetic Resonance

Response to: 'Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey' by Comarmond et al

Serum CXCL12 levels on hospital admission predict mortality in patients with severe sepsis/septic shock

Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli

The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature and of 10 new cases.

Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance: Report of Two Cases and Rationale for Its Therapeutic Use

Tocilizumab in patients with multisystem Erdheim-Chester disease

Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.

Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition